 Home > Active Ingredient News > Antitumor Therapy > CheckMate-743 Phase III study results: First-line treatment of unresectable malignant pleural mesothelioma, nivolumab combined with ipilimumab showed long-lasting benefits

CheckMate-743 Phase III study results: First-line treatment of unresectable malignant pleural mesothelioma, nivolumab combined with ipilimumab showed long-lasting benefits

 Last Update: 2021-09-18
 Source: Internet
 Author: User

Tags

chemotherapy

anagen phase hair

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On September 13, 2021, Bristol-Myers Squibb announced today that the three-year follow-up data from the CheckMate-743 clinical study showed that compared with platinum-containing standard chemotherapy, Odivo (Navulumab) combined Yiwo (Ipilimumab) has shown long-lasting survival benefits for the first-line treatment of unresectable malignant pleural mesothelioma (MPM)
.

Previously reported: CheckMate-743 is the first and only phase III clinical trial to prove that first-line immunotherapy can improve the survival benefit of patients with malignant pleural mesothelioma

CheckMate-743 is the first and only proven first-line immune therapy can improve survival benefit in patients with malignant pleural mesothelioma Phase III clinical trial of immune
diagnostic tumor immunity management FDA in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Wholesale Cheap Price Bulk Price Aclarubicin CAS 57576-44-0

CAS No.: 57576-44-0

$1/UNIT FOB

Vandetanib

CAS No.: 443913-73-3

Different Grade

$0.1/KG EXW

Camptothecin CAS 7689-03-4

CAS No.: 7689-03-4

Pharmacy Grade

$38-45/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.